#USA #Alpharetta #ADHD #Relexxii #Medfinder

Tackling ADHD Medication Access Challenges

In a significant move aimed at improving access to ADHD medication, Vertical Pharmaceuticals, part of Alora Pharmaceuticals, has announced a collaboration with Medfinder. This strategic partnership is designed to assist patients prescribed Relexxii® (methylphenidate hydrochloride extended-release tablets) in finding pharmacies that have the medication in stock during the ongoing shortages affecting ADHD treatments.

As reported by the American Academy of Child and Adolescent Psychiatry, many families across the U.S. are facing challenges in locating pharmacies that can supply stimulant medications for their prescribed treatments. In various instances, patients and their caregivers can spend considerable time and effort reaching out to multiple pharmacies, only to encounter rapid changes in inventory that prevent them from obtaining their prescriptions in a timely manner.

Relexxii is widely available across pharmacies in the country, but variability exists in how frequently specific strengths are stocked or how promptly they can be ordered. Recognizing this issue, the partnership with Medfinder is a groundbreaking initiative that allows patients to utilize an AI-powered pharmacy search tool, enabling them to find nearby pharmacies with available stock of their prescribed medication without incurring any costs.

Simplifying the Search Process

Shannon Faught, Chief Commercial Officer of Alora Pharmaceuticals, emphasized the importance of this collaboration: "We recognize how disruptive medication access challenges can be for families managing ADHD. Our partnership with Medfinder is one way we are working to help patients access Relexxii when prescribed by their healthcare provider." This sentiment is echoed by Peter Daggett, Co-Founder and CEO of Medfinder, who shared, "Our goal is to help reduce the time, uncertainty, and frustration involved in locating a pharmacy that can fill a prescription."

With the Medfinder service, patients or their caregivers can quickly identify pharmacies that report available stocks or have the capability to order the medication, thereby minimizing the traditional procedural delays that have caused distress for many. Once a pharmacy confirms availability, patients can seamlessly coordinate with their healthcare providers to send prescriptions for fulfillment.

A Resilient Response to Medication Shortages

Since the inception of this partnership, Medfinder has already facilitated over 18,000 stock checks for Relexxii. This program not only streamlines the process for patients but also ensures consistent communication between pharmacies and health care providers, ultimately enhancing the overall treatment experience for individuals dealing with ADHD.

Patients are encouraged to be informed about their treatment, including the benefits and potential risks associated with medications like Relexxii. It is crucial to note that all prescription medications come with certain considerations, and consulting healthcare providers for personalized treatment plans remains essential.

In conclusion, the partnership between Vertical Pharmaceuticals and Medfinder stands out as a proactive response to the pressing issue of medication shortages in ADHD treatments. By simplifying the search process and enhancing accessibility, both organizations are taking significant steps to ensure that patients receive the care they need without unnecessary delays.